A lawyer for Dr. Melgen in the Florida trial, Kirk Ogrosky, said the doctor views the two cases as completely separate.
âIt will have no impact on what will happen in New Jersey,â Mr. Ogrosky said in a phone interview. âHe intends to go to trial in New Jersey in September, and nothing about the Florida case changes that.â
A lawyer for Mr. Menendez said that the senator was âsaddened for his longtime friendâ but that the conviction in Florida would have âno bearingâ on the bribery charges against his client.
âThis verdict will have no impact on him,â the lawyer, Abbe David Lowell, said in a statement. âDr. Melgenâs case focused solely on the day-to-day operations of his medical practice and the private care of his patients â specifics of which the senator could not be aware, nor has it ever been suggested otherwise.â
Mr. Menendez and Dr. Melgen have pleaded not guilty to the bribery charges, and Mr. Menendez has spent two years aggressively fighting them. They have been close friends since the 1990s, and the bribery charges revolve around their relationship.
Dr. Melgen gave $700,000 through his company, Vitreo-Retinal Consultants, to the Senate Majority PAC, a so-called super PAC to support Senate Democrats, and instructed that the contributions aid Mr. Menendezâs 2012 re-election campaign.
For the help Mr. Menendez received, prosecutors contend, the senator urged the Obama administration to alter the Medicare reimbursement policy in a way that would make millions for Dr. Melgen. In 2012 alone, Dr. Melgen received $21 million in Medicare reimbursements.
In addition, prosecutors said, Mr. Menendez tried to push a port security deal that involved Dr. Melgen and worked to obtain United States travel visas for the doctorâs foreign girlfriends.
Mr. Menendez was rewarded for his help, according to prosecutors, and received free trips on Dr. Melgenâs jet and spent three nights in an executive suite in Paris for a trip valued at nearly $5,000. After an ethics complaint was filed against Mr. Menendez for not reporting trips to the Dominican Republic as gifts, he wrote a $58,500 check to reimburse Dr. Melgenâs company.
Federal investigators started to look into Dr. Melgenâs billings to Medicare because he was charging a significantly higher rate for a medication to treat macular degeneration than his peers were. The government said he billed for one vial of the medicine for each patient when he had in fact used one vial to treat three or four patients.
Mr. Menendez came under federal scrutiny when…